Pharmacokinetics and hypolipidemic activity of clofibrate-nicotinic acid combinations in rats. 1979

M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D009539 Nicotinic Acids 2-, 3-, or 4-Pyridinecarboxylic acids. Pyridine derivatives substituted with a carboxy group at the 2-, 3-, or 4-position. The 3-carboxy derivative (NIACIN) is active as a vitamin. Acids, Nicotinic
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
September 1972, Canadian Medical Association journal,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
January 1978, Zeitschrift fur Versuchstierkunde,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
April 1977, Nutrition reviews,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
January 1979, General pharmacology,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
January 1979, General pharmacology,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
September 1978, Clinical pharmacology and therapeutics,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
December 1970, Acta medica Scandinavica,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
January 2003, Revista medico-chirurgicala a Societatii de Medici si Naturalisti din Iasi,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
April 2012, Toxicological sciences : an official journal of the Society of Toxicology,
M N Cayen, and W T Robinson, and J Dubuc, and D Dvornik
May 1986, Biochemical pharmacology,
Copied contents to your clipboard!